NASDAQ · Biotechnology

Dogwood Therapeutics, Inc. (DWTX) Stock

$1.40 -0.71% NASDAQ: DWTX Healthcare

Valuation

MetricValue
Price$1.40
Market Cap$47.08M
P/E Ratio-0.18
P/B Ratio0.80
P/S Ratio0.00
EPS (TTM)$-4.32
52-Week High$7.20
52-Week Low$1.28
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-47.85%
ROA-44.77%
ROCE-38.07%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-16.0M$-12.0M$-5.0M$-12.0M$-28.0M
Net Profit$-16.0M$-12.0M$-5.0M$-12.0M$-34.0M
EPS$-47.90$-27.66$-7.05$-12.52$-4.32
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$16.0M$8.0M$4.0M$94.0M$90.0M
Total Liabilities$1.0M$1.0M$0$30.0M$15.0M
Cash$14.0M$7.0M$3.0M$15.0M$7.0M
Borrowings$0$0$0$16.0M$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-16.0M$-11.0M$-5.0M$-9.0M$-16.0M
Investing Cash Flow$0$0$0$4.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-16.0M$-7.0M$-4.0M$12.0M$-8.0M
Free Cash Flow$-16.0M$-11.0M$-5.0M$-9.0M$-16.0M

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc. is led by CEO Gregory Duncan, employs 12 people, headquartered in US, publicly traded since 2020.

Dogwood Therapeutics, Inc. (DWTX) stock trades at $1.40 with a market capitalization of $47.08M. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of 0.80, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.28 and $7.20, and currently trades 80.6% below its 52-week high.

On profitability, Dogwood Therapeutics, Inc. generates a return on equity (ROE) of -47.85%, return on capital employed of -38.07%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides